RTW INVESTMENTS, LP - 31 Mar 2025 SCHEDULE 13G Report for Tenax Therapeutics, Inc. Common Stock, $0.0001 par value per share (TENX)

Filing Manager
RTW INVESTMENTS, LP
Reporting Manager
RTW Investments, LP
Security
Tenax Therapeutics, Inc. Common Stock, $0.0001 par value per share
Symbol
TENX
Shares outstanding
4,188,589 shares
Disclosed Ownership
418,440 shares
Ownership
10%
Form type
SCHEDULE 13G
Filing time
15 May 2025, 08:34:15 UTC
Date of event
31 Mar 2025
Next filing
17 Feb 2026
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"RTW INVESTMENTS, LP disclosed 10% ownership in Tenax Therapeutics, Inc. Common Stock, $0.0001 par value per share (TENX) on 31 Mar 2025."

Quick Takeaways

  • RTW INVESTMENTS, LP filed SCHEDULE 13G for Tenax Therapeutics, Inc. Common Stock, $0.0001 par value per share (TENX).
  • Disclosed ownership: 10%.
  • Date of event: 31 Mar 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 15 May 2025, 08:34.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
RTW Investments, LP 10% 418,440 0 418,440 /s/ Roderick Wong, M.D. Roderick Wong, M.D., Managing Partner
Roderick Wong, M.D. 10% 418,440 0 418,440 /s/ Roderick Wong, M.D. Roderick Wong, M.D.

Sponsored